Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa Neuroprotective efficacy of topical unoprostoneisopropyl or nipradilol in patients with retinitis pi ...
Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa - Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa Neuroprotective efficacy of topical unoprostoneisopropyl or nipradilol in patients with retinitis pi ...
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa
retinitis pigmentosa
Intervention name : UF-021 (isopropyl unoprostone) Dosage And administration of the intervention : Eye drop Intervention name : UF-021 (isopropyl unoprostone) Dosage And administration of the intervention : Ey ...
Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Mask ...
Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Mask ...
Retinitis Pigmentosa
Intervention name : UF-021(isopropyl unoprostone) Dosage And administration of the intervention : Eye drop Control intervention name : null Intervention name : UF-021(isopropyl unoprostone) Dosage And administration of the intervention : Eye ...